BR vs CLDX · P/E 16, rev $7.48B vs rev $7.0M
Broadridge Financial Solutions Inc (BR) versus Celldex Therapeutics Inc (CLDX) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Latest reported BR revenue for 2026-06-30 was $7.48B. Net income was $1.12B. Revenue was up 8.5% from 2025-06-30 to 2026-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported CLDX revenue for 2024-12-31 was $7.0M. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. CLDX currently screens at market cap $2.35B.
BR currently screens at market cap $17.65B and trailing P/E 16.3. CLDX currently screens at market cap $2.35B.
Not investment advice. Open the BR and CLDX stock pages for the full models.
Not investment advice.